Table 3. External validation of the calculator for 5-year mortality.
| Patients group | No. | Mean predictive rate | 95% CI | Actual rate |
|---|---|---|---|---|
| Overall | 916 | 0.7192 | 0.4494 to 0.9684 | 0.8280 |
| Neutrophil/lymphocyte ratio | ||||
| <4 | 643 | 0.7002 | 0.4494 to 0.8786 | 0.7994 |
| ≥4 | 184 | 0.9356 | 0.8326 to 0.9850 | 0.9293 |
| Synchronous metastasis | ||||
| Absent | 462 | 0.6036 | 0.4494 to 0.9010 | 0.7554 |
| Present | 448 | 0.8618 | 0.7330 to 0.9850 | 0.8996 |
| No. of metastasis | ||||
| <2 | 379 | 0.6864 | 0.4494 to 0.9550 | 0.7652 |
| ≥2 | 476 | 0.8005 | 0.5404 to 0.9850 | 0.8824 |
| Albumin (g/dL) | ||||
| ≥3 | 728 | 0.7377 | 0.4494 to 0.9684 | 0.8132 |
| <3 | 51 | 0.9528 | 0.8219 to 0.9850 | 0.9804 |
| Hb (g/dL) | ||||
| ≥LLN (male 13, female 11.5) | 372 | 0.6475 | 0.4494 to 0.9436 | 0.7473 |
| <LLN (male 13, female 11.5) | 458 | 0.8321 | 0.5989 to 0.9850 | 0.8930 |
CI, confidence interval; Hb, hemoglobin; LLN, lower limit of normal.